Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/21/2025 | $71.00 | Equal Weight | Barclays |
| 3/6/2025 | $190.00 → $125.00 | Outperform | Telsey Advisory Group |
| 1/10/2025 | $173.00 → $220.00 | Neutral → Buy | UBS |
| 12/20/2024 | $201.00 → $204.00 | Overweight | Analyst |
| 12/6/2024 | $180.00 | Outperform | Raymond James |
| 8/30/2024 | $190.00 | Neutral → Buy | Citigroup |
| 8/29/2024 | $208.00 → $190.00 | Outperform | Telsey Advisory Group |
| 7/22/2024 | $167.00 → $194.00 | Neutral → Overweight | JP Morgan |
4 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Issuer)
4 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Issuer)
4 - ABERCROMBIE & FITCH CO /DE/ (0001018840) (Issuer)